We are pleased to announce that our consultant, Dr. Rebecca Arend of the University of Alabama at Birmingham (UAB), currently has two clinical trials that are dedicated to the treatment of carcinosarcoma patients!
This trial is tailored specifically for recurrent carcinosarcoma patients.
This clinical trial is being conducted at the University of Alabama at Birmingham.
This clinical trial is being conducted at 17 locations in the US, including the University of Alabama, Birmingham, AL.
Dr. Rebecca Arend, MD is the Principal Investigator for this multi-site study.
For more information on clinical trials, please click here.
Our sister never–not for a minute–lost hope. March marks the third anniversary we remember our sister, Diane Redington, who lost her courageous three-year battle to gynecologic carcinosarcoma (GCS/MMMT) on March… Read More »
Dr. Arend, an assistant professor and senior scientist at the University of Alabama at Birmingham has received funding from 2 drug companies – Bristol Meyers Squib and Exelixis to perform… Read More »